Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
All content for Footprints & Impacts Podcast is the property of EHAC-ASEC and ASEQ-EHAQ and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
Legal Rights and Advocacy for People with MCS with Lila Refaie.
Footprints & Impacts Podcast
1 hour 11 minutes
10 months ago
Legal Rights and Advocacy for People with MCS with Lila Refaie.
Send us a text Legal Rights and Advocacy for People with Multiple Chemical Sensitivity (MCS) with Lila Refaie. In this episode of Footprints & Impacts, we are joined by Lila Refaie, Bilingual Staff Lawyer at the ARCH Disability Law Centre to discuss the legal challenges faced by individuals with Multiple Chemical Sensitivity (MCS). Lila shares her expertise on disability rights, including the legal protections available to people with MCS under the Canadian and Ontario Human Rights Act.&...
Footprints & Impacts Podcast
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
